Propranolol therapy in infantile hemangioma: correlation of age and duration of treatment to the outcomes
Abstract Background Infantile hemangioma (IH) is the commonest vascular tumor affecting children that appears in the first 2 weeks of life and follows a proliferative phase that continues during the first year of life. After then, it undergoes involution, which lasts for several months or years depe...
Main Authors: | Ali Farooq Al-Mayoof, Ali Egab Joda, Osama Esmaeel Almushhadany |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-12-01
|
Series: | Annals of Pediatric Surgery |
Online Access: | https://doi.org/10.1186/s43159-019-0007-7 |
Similar Items
-
Hemangioma infantil tratado com propranolol Propranolol treatment for hemangioma of infancy
by: Flavia Kakiuti Bonini, et al.
Published: (2011-08-01) -
Propranolol in the Treatment of Infantile Hemangiomas
by: Tan X, et al.
Published: (2021-09-01) -
Treatment of infantile hemangioma with propranolol
by: Gian Maria Pacifici -
Use of propranolol in infantile hemangioma
by: Manish K Shah, et al.
Published: (2017-01-01) -
Propranolol therapy for infantile hemangioma: our experience
by: Zhang L, et al.
Published: (2017-05-01)